Extract of Rhus verniciflua Stokes enhances Th1 response and NK cell activity

Molecular and Cellular Toxicology

Volumn 12, Issue 4, 2016, Pages 399-407

  Lee, Eui joon ^a   Lee, Gihyun ^b   Sohn, Sung Hwa ^b   Bae, Hyunsu ^b  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

NK cell; Rhus verniciflua Stokes; Th1 cells

Indexed keywords

CALCEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12 ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 5; PLANT EXTRACT; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 4; RHUS VERNICIFLUA STOKE EXTRACT; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCEIN-AM ASSAY; CD4+ T LYMPHOCYTE; CELL CONTACT; CELL POLARITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MAGNETISM; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; RHUS VERNICIFLUA STOKE; SPLEEN; TH1 CELL; TH2 CELL; TOXICODENDRON VERNICIFLUUM;

EID: 85008512330     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-016-0044-8     Document Type: Article

References (40)

1. Cheon, S. H. et al. Efficacy and safety of Rhus verniciflua stokes extracts in patients with previously treated advanced non-small cell lung cancer. Forsch Komplementarmed 18:77–83 (2011).
2. Lee, S. H., Choi, W. C. & Yoon, S. W. Impact of standardized Rhus verniciflua stokes extract as complementary therapy on metastatic colorectal cancer: a Korean single-center experience. Integr Cancer Ther 8: 148–152 (2009).
3. Lee, S. K. et al. Rhus verniciflua Stokes extract as a potential option for treatment of metastatic renal cell carcinoma: report of two cases. Ann Oncol ESMO 21: 1383–1385 (2010).
4. Kook, S. H. et al. Caspase-independent death of human osteosarcoma cells by flavonoids is driven by p53-mediated mitochondrial stress and nuclear translocation of AIF and endonuclease G. Apoptosis 12:1289–1298 (2007).
5. Lee, J. C., Kim, J. & Jang, Y. S. Ethanol-eluted extract of Rhus verniciflua stokes inhibits cell growth and induces apoptosis in human lymphoma cells. J Biochem Mol Biol 36:337–343 (2003).
6. Son, Y. O. et al. Selective antiproliferative and apoptotic effects of flavonoids purified from Rhus verniciflua Stokes on normal versus transformed hepatic cell lines. Toxicol Lett 155:115–125 (2005).
7. Samoszuk, M., Tan, J. & Chorn, G. The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts. BMC Complement Altern Med 5:5 (2005).
8. Mosmann, T. R. & Coffman, R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145–173 (1989).
9. Kuo, C. T. & Leiden, J. M. Transcriptional regulation of T lymphocyte development and function. Annu Rev Immunol 17:149–187 (1999).
10. Abbas, A. K., Murphy, K. M. & Sher, A. Functional diversity of helper T lymphocytes. Nature 383:787–793 (1996).
11. Zheng, W. & Flavell, R. A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587–596 (1997).
12. Das, J. et al. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol 2:45–50 (2001).
13. Constant, S. L. & Bottomly, K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 15:297–322 (1997).
14. Gri, G. et al. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15. Cancer Res 62:4390–4397 (2002).
15. Itoh, K., Shiiba, K., Shimizu, Y., Suzuki, R. & Kumagai, K. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma). J Immunol 134:3124–3129 (1985).
16. Bukowski, R. et al. Pegylated interferon alfa-2b treatment for patients with solid tumors: a phase I/II study. J Clin Oncol 20:3841–3849 (2002).
17. Smyth, M. J., Hayakawa, Y., Takeda, K. & Yagita, H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2:850–861 (2002).
18. Rao, A. & Avni, O. Molecular aspects of T-cell differentiation. Br Med Bull 56:969–984 (2000).
19. O’Garra, A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275–283 (1998).
20. Iizuka, N. et al. Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6. Cancer Lett 158:35–41 (2000).
21. Tode, T. et al. In vitro and in vivo effects of ginsenoside Rh2 on the proliferation of serous cystadenocarcinoma of the human ovary. Nihon Sanka Fujinka Gakkai Zasshi 44:589–594 (1992).
22. Tode, T. et al. Inhibitory effects of oral administration of ginsenoside Rh2 on tumor growth in nude mice bearing serous cyst adenocarcinoma of the human ovary. Nihon Sanka Fujinka Gakkai Zasshi 45:1275–1282 (1993).
23. See, D. M., Broumand, N., Sahl, L. & Tilles, J. G. In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 35:229–235 (1997).
24. Lee, J. C., Lim, K. T. & Jang, Y. S. Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties. Biochimica et Biophysica Acta 1570:181–191 (2002).
25. Lim, K. T., Hu, C. & Kitts, D. D. Antioxidant activity of a Rhus verniciflua Stokes ethanol extract. Food Chem Toxicol 39:229–237 (2001).
26. Kitts, D. D. & Lim, K. T. Antitumorigenic and cytotoxic properties of an ethanol extract derived from Rhus verniciflua Stokes (RVS). J Toxicol Environ Health A 64:357–371 (2001).
27. Hong, D. H. et al. Cytotoxicity of urushiols isolated from sap of Korean lacquer tree (Rhus vernicifera Stokes). Arch Pharm Res 22:638–641 (1999).
28. Ames, B. N., Shigenaga, M. K. & Hagen, T. M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 90:7915–7922 (1993).
29. Park, K. Y. et al. Antimutagenic activity of flavonoids from the heartwood of Rhus verniciflua. J Ethnopharmacol 90:73–79 (2004).
30. Lim, K. T., Lee, S. J., Heo, K. S. & Lim, K. Effects of glycoprotein isolated from Rhus verniciflua stokes on TPA-induced apoptosis and production of cytokines in cultured mouse primary splenocytes. Toxicol Lett 145: 261–271 (2003).
31. Hong, S. H. et al. Anti-oxidant and natural killer cell activity of Korean red ginseng (Panax ginseng) and urushiol (Rhus vernicifera Stokes) on non-alcoholic fatty liver disease of rat. Food Chem Toxicol 55:586–591 (2013).
32. Ravaglia, G. et al. Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged =90 y. Am J Clin Nutr 71:590–598 (2000).
33. Park, S. D., Lee, S. W., Chun, J. H. & Cha, S. H. Clinical features of 31 patients with systemic contact dermatitis due to the ingestion of Rhus (lacquer). Br J Dermatol 142:937–942 (2000).
34. Szabo, S. J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655–669 (2000).
35. Gough, M. J. et al. Macrophages orchestrate the immune response to tumor cell death. Cancer Res 61: 7240–7247 (2001).
36. Teng, M. N. et al. Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity. Proc Natl Acad Sci U S A 88:3535–3539 (1991).
37. Ruegg, C. et al. Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat Med 4:408–414 (1998).
38. Fiorentino, D. F. et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444–3451 (1991).
39. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. & Coffman, R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348–2357 (1986).
40. Seder, R. A., Paul, W. E., Davis, M. M. & Fazekas de St Groth, B. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med 176:1091–1098 (1992).